Violante Di Donato

No ORCID on file · 21 papers in corpus · active 2013-2026

Study types

  • article 5
  • review 5
  • meta-analysis 1

Condition tags

  • endometriosis 6
  • endometrioma 4
  • chronic_pelvic_pain 3
  • infertility 3
  • dysmenorrhea 1
  • dyspareunia 1
article 2026
·doi:10.1016/j.ijgc.2025.103566
2025
International journal of molecular sciences ·doi:10.3390/ijms26189253

Green tea, long consumed across Southeast Asia, is highly esteemed for its medicinal properties and is often favored over conventional treatments in Eastern cultures. Its health benefits are largely attributed to its minimal processing, whi…

2025
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare13151780

Iatrogenic urinary tract injury is a known complication of pelvic surgery, most commonly occurring during gynecological procedures. The bladder and ureters are particularly vulnerable due to their close anatomical proximity to the uterus. U…

2025
Cancers ·doi:10.3390/cancers17243915

Epithelial ovarian cancer (EOC) remains the most lethal gynecological malignancy worldwide, primarily due to late-stage diagnosis, limited early screening tools, and the aggressive nature of the disease. Increasing global efforts have been …

2025
Cancers ·doi:10.3390/cancers17091473

Background: Serum biomarkers such as Carcinoma Antigen 125 (CA125) and Human Epididymis Protein 4 (HE4) are widely used in the diagnosis and prognosis of gynecological malignancies. Serum biomarkers such as CA125 and HE4 represent essential…

2024
International journal of molecular sciences ·doi:10.3390/ijms252011239

Growing evidence has demonstrated the role of mutations of tumor biomarkers in diagnosing and treating epithelial ovarian cancer. This review aims to analyze recent literature on the correlation between tumor biomarkers and chemotherapy in …

review 2023
Journal of clinical medicine ·doi:10.3390/jcm12051858

Management options for ovarian endometriomas include expectant management, medical treatment, surgical treatment, in vitro fertilization (IVF), or a combination of the above. The choice of management depends on many clinical parameters that…

meta-analysis 2023
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-023-01266-0

The objective of this study is to determine whether dienogest therapy after endometriosis surgery reduces the risk of recurrence compared with placebo or alternative treatments (GnRH agonist, other progestins, and estro-progestins). The des…

2022
Journal of clinical medicine ·doi:10.3390/jcm11113114

This systematic review identifies, evaluates, and summarises the findings of all relevant individual studies on the prevalence of BRCA mutation (BRCAm) in endometrial cancer patients and the incidence of endometrial cancer in BRCAm women pa…

2022
Journal of clinical medicine ·doi:10.3390/jcm11236940

Hysterectomy is one of the most common non-obstetric gynecological surgical procedures carried out in Western countries [...].

2022
Cancers ·doi:10.3390/cancers14235881

High- and low-risk endometrial carcinoma (EC) differ in whether or not a lymphadenectomy is performed. We aimed to develop MRI-based radio-genomic models able to preoperatively assess lymph-vascular space invasion (LVSI) and discriminate be…

2021
Journal of gynecologic oncology ·doi:10.3802/jgo.2021.32.e83

ObjectiveTo investigate current evidence on oncological, fertility and obstetric outcomes of patients with stage I cervical cancer of 4 cm or larger undergoing fertility-sparing surgery (FSS).MethodsSystematic review of studies including wo…

2021
Biomedicines ·doi:10.3390/biomedicines9010055

Even though 80% of patients with High-Grade Serous Ovarian Cancer respond to standard first-line chemotherapy, a majority of them could relapse in the following five years due to a resistance to platinum. Human Epididymis protein 4 (HE4) is…

article 2019
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2019.1640199

The aim of the present study was to evaluate the effect of medical treatment of ovarian endometriomas on cyst diameter, associated pain, and ovarian reserve as measured with antral follicle count (AFC) and anti-Mullerian hormone (AMH). In t…

review 2018
Fertility and sterility ·doi:10.1016/j.fertnstert.2018.06.025

ObjectiveTo evaluate if the presence of endometriomas impacts on the ovarian reserve as evaluated with antimüllerian hormone (AMH).DesignSystematic review and meta-analysis.SettingNot applicable.Patient(s)Patients with unoperated endometrio…

review 2017
·doi:10.1055/s-0037-1606279

It has been brought to our attention that the names ChiaraDi Tucci andMara Di Feliciantonio were indexed incorrectly in the above article in Seminars in Reproductive Medicine, Volume 35, Number 1, 2017 (DOI 10.1055/s-0036-1597126). The auth…

article 2016
·doi:10.1097/01.ogx.0000485004.91483.16

(Abstracted from Am J Obstet Gynecol 2016;214:203–211) Up to 44% of patients with endometriosis have endometriomas that are usually associated with pelvic pain and infertility. The first-line option for endometriosis-associated pain symptom…

review 2016
Seminars in reproductive medicine ·doi:10.1055/s-0036-1597126

Ovarian endometriomas affect 17 to 44% of women with endometriosis, and are often associated with pelvic pain and infertility. Treatment options include expectant management, medical and/or surgical treatment, and in vitro fertilization and…

review 2015
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2015.08.074

In the lack of evidence consistently supporting the use of continuous vs cyclic oral contraceptives after surgery for endometriosis, we conducted a systematic review and metaanalysis with the objective of comparing a continuous vs a cyclic …

article 2015
·doi:10.1016/j.jmig.2015.08.503
article 2013
·doi:10.1016/j.jmig.2013.08.023